Get App Open
In App
Credit Cards
Open App

Anthem Biosciences Ltd.

BSE: 544449 | NSE: ANTHEM |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE0CZ201020 | SECTOR: Pharmaceuticals & Drugs

BSE Live

Dec 02, 16:01
652.30 -7.35 (-1.11%)
Volume
AVERAGE VOLUME
5-Day
912,269
10-Day
487,292
30-Day
209,045
15,781
  • Prev. Close

    659.65

  • Open Price

    659.80

  • Bid Price (Qty.)

    650.70 (10)

  • Offer Price (Qty.)

    652.30 (15)

NSE Live

Dec 02, 15:59
652.50 -6.90 (-1.05%)
Volume
AVERAGE VOLUME
5-Day
909,735
10-Day
1,548,337
30-Day
1,457,530
195,314
  • Prev. Close

    659.40

  • Open Price

    659.00

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    652.50 (17)

Financials

Profit & Loss account of Anthem Biosciences (in Rs. Cr.) Mar 25 Mar 24 Mar 23 Mar 22 Mar 21  
  12 mths 12 mths 12 mths 12 mths 12 mths  
INCOME  
Revenue From Operations [Gross] 1,840.65 1,417.54 1,056.92 1,231.26 1,103.24  
Less: Excise/Sevice Tax/Other Levies 0.00 0.00 0.00 0.00 0.00  
Revenue From Operations [Net] 1,840.65 1,417.54 1,056.92 1,231.26 1,103.24  
Total Operating Revenues 1,840.65 1,417.54 1,056.92 1,231.26 1,103.24  
Other Income 109.44 70.52 77.37 48.98 37.21  
Total Revenue 1,950.09 1,488.06 1,134.30 1,280.24 1,140.45  
EXPENSES  
Cost Of Materials Consumed 828.08 640.77 348.29 410.30 407.88  
Purchase Of Stock-In Trade 0.00 0.00 0.00 0.00 0.00  
Operating And Direct Expenses 0.00 0.00 0.00 0.00 0.00  
Changes In Inventories Of FG,WIP And Stock-In Trade -86.70 -41.23 -9.01 -1.37 39.12  
Employee Benefit Expenses 252.17 182.65 153.24 137.51 142.19  
Finance Costs 9.09 9.14 6.75 10.09 16.97  
Depreciation And Amortisation Expenses 77.94 81.49 63.70 57.76 62.40  
Other Expenses 158.10 130.47 135.35 119.36 106.32  
Total Expenses 1,238.67 1,003.29 698.32 733.64 774.87  
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax 711.42 484.77 435.98 546.59 365.58  
Exceptional Items 0.00 0.00 61.80 0.00 0.00  
Profit/Loss Before Tax 711.42 484.77 497.78 546.59 365.58  
Tax Expenses-Continued Operations  
Current Tax 182.03 126.41 120.05 142.39 96.70  
Less: MAT Credit Entitlement 0.00 0.00 0.00 0.00 0.00  
Deferred Tax 23.21 -16.42 -7.94 -1.79 -2.43  
Tax For Earlier Years 0.00 0.00 0.00 0.00 0.00  
Total Tax Expenses 205.24 109.99 112.11 140.60 94.27  
Profit/Loss After Tax And Before ExtraOrdinary Items 506.19 374.78 385.67 405.99 271.31  
Profit/Loss From Continuing Operations 506.19 374.78 385.67 405.99 271.31  
Profit/Loss For The Period 506.19 374.78 385.67 405.99 271.31  
OTHER ADDITIONAL INFORMATION  
EARNINGS PER SHARE  
Basic EPS (Rs.) 9.05 6.61 6.77 462.98 323.43  
Diluted EPS (Rs.) 9.01 6.61 6.77 462.95 323.41  
VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS  
Imported Raw Materials 0.00 0.00 0.00 0.00 0.00  
Indigenous Raw Materials 0.00 0.00 0.00 0.00 0.00  
STORES, SPARES AND LOOSE TOOLS  
Imported Stores And Spares 0.00 0.00 0.00 0.00 0.00  
Indigenous Stores And Spares 0.00 0.00 0.00 0.00 0.00  
DIVIDEND AND DIVIDEND PERCENTAGE  
Equity Share Dividend 0.00 0.00 0.00 0.00 0.00  
Tax On Dividend 0.00 0.00 0.00 0.00 0.00  
Equity Dividend Rate (%) 0.00 0.00 0.00 0.00 0.00  
Source : Dion Global Solutions Limited

Results of Pharmaceuticals & Drugs Sector

  • 01.01.1970

  • 01.01.1970

  • 01.01.1970

  • 01.01.1970

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347